Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis
article
OA: closed
CC0
⤵ 19 in-corpus citations
AI-generated summary
Medroxyprogesterone acetate and danazol treatments failed to restore normal interleukin-6 suppression in endometrial stromal cells from women with adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo examine changes in local cytokine production in the eutopic endometrium of adenomyosis after treatment with medroxyprogesterone acetate (MPA) and danazol.DesignProspective cohort study.SettingTertiary university hospital.Patient(s)Twenty-four women with adenomyosis (study group) and 22 women without adenomyosis (control group).Intervention(s)Eutopic endometrium was separated into single endometrial stromal cells (ESCs), and was cultured in vitro alone, with MPA (10(-7) M), or with danazol (10(-7) M) for 8 days.Main outcome measure(s)Messenger RNA expression of interleukin (IL)-6, IL-8, and tumor necrosis factor-alpha in ESCs, and their concentrations in the supernatants of ESCs.Result(s)A significant decrease of IL-6 concentration in the supernatant, measured by ELISA, was found with time of ESCs cultured with MPA and danazol in the control group, but not in adenomyosis. The IL-6 mRNA in ESCs determined by real-time quantitative polymerase chain, as well as its concentration in the supernatant, was much higher in adenomyosis than that in the control group after treatment with MPA and danazol for 8 days.Conclusion(s)Medroxyprogesterone acetate and danazol appeared to have a decreased effect on the suppression of IL-6 liberated by ESCs in adenomyosis. This aberrant secretion of IL-6 might play a role in the formation of ectopic endometrial implants in adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository via openalex
- Danazol inhibits steroidogenesis by the human ovary in vivo via openalex
- Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis via openalex
- Evidence for estrogen synthesis in adenomyotic tissues via openalex
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas via openalex
- Human endometrial interleukin-6 (IL-6): in vivo messenger ribonucleic acid expression, in vitro protein production, and stimulation thereof by IL-1β via openalex
- Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. via openalex
- Interleukin-8 in the Human Endometrium<sup>1</sup> via openalex
- Long-Term Progestin Treatment Inhibits RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) Gene Expression in Human Endometrial Stromal Cells via openalex
- Pathogenetic Significance of Increased Levels of Interleukin-8 in the Peritoneal Fluid of Patients with Endometriosis via openalex
- Steroid and Cytokine Regulation of Matrix Metalloproteinase Expression in Endometriosis and the Establishment of Experimental Endometriosis in Nude Mice via openalex
- Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. via openalex
- W2036260249 via openalex
- W2051978298 via openalex
- W2069753865 via openalex
- W2074613170 via openalex
- W2082068040 via openalex
- W2122902311 via openalex
- W2133376231 via openalex
- W2134170527 via openalex
- W2166744769 via openalex
- W2282336047 via openalex
- W4250972286 via openalex
- W6605646629 via openalex
- W6641761785 via openalex
- W6668025391 via openalex
- W6833068047 via openalex
- W84583857 via openalex
- W140601849 via openalex
- W1964920982 via openalex
- W1978349904 via openalex
- W1986075242 via openalex
- W1992912767 via openalex
- W2000139492 via openalex
- W2006584323 via openalex
- W2015629565 via openalex
- W2020726697 via openalex
- W2029790299 via openalex
Cited by (20)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Endometrial cell‑derived exosomes facilitate the development of adenomyosis via the IL‑6/JAK2/STAT3 pathway 2023
- Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development 2022
- Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 2021
- Activation of the cGAS–STING signaling pathway in adenomyosis patients 2021
- The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea 2020
- Immunological changes associated with adenomyosis: a systematic review 2020
- Berberine inhibits the LPS‑induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway 2017
- Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment 2017
- Synthetic Steroid Hormones Regulated Cell Proliferation Through MicroRNA-34a-5p in Human Ovarian Endometrioma1 2016
- Effects of Levonorgestrel-Releasing Intrauterine System on Lymphangiogenesis of Adenomyosis 2015
- The Endometrium in Adenomyosis 2015
- Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells. 2015
- L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner. 2014
- The Endometrium in Adenomyosis 2012
- Mise au point sur l’adénomyose 2012
- Expression and possible role of interleukin-10 receptors in patients with adenomyosis 2012
- Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis 2008
- Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis 2007
- Evolution of medical treatment for endometriosis: back to the roots? 2007
Source provenance
- europepmc
- last seen: 2026-09-06T09:34:12.023084+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:12.369988+00:00
- unpaywall
- last seen: 2026-08-12T06:43:03.944938+00:00
License: CC0
· commercial use OK